Like other major pharmaceutical companies, Merck also dealt with competition from generic drugmakers, which helped push down total prescription drug revenue per cent in the fourth quarter. 머크의 주가는 한 해 동안 퍼센트 하락하여 다음과 같이 마감했습니다. In contrast, the Stand Poors index climbed.